Accel Wealth Management Purchases Shares of 21,615 Medical Properties Trust, Inc. (NYSE:MPW)

Accel Wealth Management purchased a new stake in shares of Medical Properties Trust, Inc. (NYSE:MPW) in the 4th quarter, HoldingsChannel reports. The firm purchased 21,615 shares of the real estate investment trust’s stock, valued at approximately $106,000.

Several other institutional investors have also added to or reduced their stakes in the business. Kingswood Wealth Advisors LLC purchased a new stake in Medical Properties Trust during the fourth quarter valued at about $109,000. Pacer Advisors Inc. boosted its holdings in shares of Medical Properties Trust by 79.4% during the fourth quarter. Pacer Advisors Inc. now owns 90,051 shares of the real estate investment trust’s stock worth $442,000 after purchasing an additional 39,856 shares during the period. Adams Asset Advisors LLC boosted its holdings in shares of Medical Properties Trust by 21.1% during the fourth quarter. Adams Asset Advisors LLC now owns 392,129 shares of the real estate investment trust’s stock worth $1,925,000 after purchasing an additional 68,290 shares during the period. Handelsinvest Investeringsforvaltning purchased a new stake in shares of Medical Properties Trust during the fourth quarter worth about $259,000. Finally, Fulcrum Capital LLC boosted its holdings in shares of Medical Properties Trust by 30.7% during the fourth quarter. Fulcrum Capital LLC now owns 31,500 shares of the real estate investment trust’s stock worth $155,000 after purchasing an additional 7,400 shares during the period. 71.79% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on MPW. JPMorgan Chase & Co. dropped their target price on shares of Medical Properties Trust from $8.00 to $5.00 and set an “underweight” rating for the company in a report on Wednesday, November 29th. BNP Paribas upgraded shares of Medical Properties Trust from a “neutral” rating to an “outperform” rating and set a $6.00 target price for the company in a report on Friday, March 1st. Mizuho decreased their price target on shares of Medical Properties Trust from $9.00 to $7.00 and set a “neutral” rating for the company in a research note on Wednesday, January 3rd. KeyCorp reissued a “sector weight” rating on shares of Medical Properties Trust in a research note on Friday, January 5th. Finally, Deutsche Bank Aktiengesellschaft started coverage on shares of Medical Properties Trust in a research note on Tuesday, January 30th. They issued a “sell” rating and a $2.00 price target for the company. Six research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $6.59.

Medical Properties Trust Stock Down 0.4 %

Shares of NYSE MPW traded down $0.02 on Thursday, reaching $4.70. 24,035,020 shares of the company’s stock traded hands, compared to its average volume of 24,402,527. Medical Properties Trust, Inc. has a 12 month low of $2.92 and a 12 month high of $10.74. The business’s 50 day simple moving average is $3.80 and its two-hundred day simple moving average is $4.52. The company has a market cap of $2.82 billion, a price-to-earnings ratio of -5.00, a price-to-earnings-growth ratio of 1.12 and a beta of 1.19. The company has a quick ratio of 2.26, a current ratio of 2.26 and a debt-to-equity ratio of 1.32.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.